Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies
Authors:
- Fernando Daibert de Souza MottaFMFernando Daibert de Souza Motta
- Matheus de Lima RuffiniMRMatheus de Lima Ruffini
- Amanda Cunha RitterARAmanda Cunha Ritter
- Nicole da Silva MastellaNMNicole da Silva Mastella
- Bruno Braga MontezanoBMBruno Braga Montezano
- Elias AjubEAElias Ajub
- Flávio KapczinskiFKFlávio Kapczinski
- Jairo Vinícius PintoJPJairo Vinícius Pinto
- Ives Cavalcante PassosIPIves Cavalcante Passos
Open Access
- 20 October 2026
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
Abstract
Introduction: Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality. Although clinically important, the absolute burden and incidence of cardiovascular outcomes in BD remain incompletely characterized. This systematic review and meta‐analysis synthesized observational evidence on CVD prevalence and incidence in adults with BD. Methods: Following PRISMA guidelines and prospectively registered in PROSPERO (CRD42023484712), we searched PubMed, Web of Science, Embase, Scopus, and PsycInfo, screening 11,909 records. Thirty‐two observational studies in adults with BD were included after Newcastle–Ottawa Scale assessment. Data were extracted on overall CVD, coronary artery disease, cerebrovascular disease, peripheral arterial disease, comorbidities, and psychotropic exposure. Pooled prevalence and incidence rate ratios were calculated using random‐effects models when data were comparable. Results: The pooled CVD prevalence in BD was 7.70% (95% CI: 5.07–11.52), with coronary artery disease at 6.89% (95% CI: 4.05–11.47), cerebrovascular disease at 4.45% (95% CI: 2.13–9.05), and peripheral arterial disease at 3.30% (95% CI: 1.66–6.45). However, prevalence estimates showed extreme heterogeneity and should be interpreted as broad indicators of absolute burden rather than precise estimates for a single BD population. In controlled incidence studies, BD was associated with increased CVD incidence (IRR 1.66, 95% CI: 1.32–2.08), with elevated coronary and cerebrovascular estimates. Clinical variable analyses involving medication use, lifestyle factors, and cardiometabolic comorbidities were not feasible because reporting was insufficient and noncomparable. Conclusion: Adults with BD show substantial cardiovascular burden and increased incidence. However, extreme heterogeneity, limited incidence data, observational designs, and insufficient moderator reporting limit the precision and generalizability of pooled estimates. These findings support integrated cardiovascular screening in BD populations and future prospective studies. Trail Registration: PROSPERO CRD42023484712Keywords
Funding Information
- Ministério da Saúde (45/2022)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (408187/2022‐0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 50 references indexed in Scilit:
- Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: A systematic review and meta-analysisEuropean Neuropsychopharmacology, 2024
- Comorbid physical health outcomes in patients with bipolar disorder: An umbrella review of systematic reviews and meta-analysesAsian Journal of Psychiatry, 2024
- Mental health conditions and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort studyGeneral Hospital Psychiatry, 2022
- Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trialsEuropean Neuropsychopharmacology, 2020
- Cochrane Handbook for Systematic Reviews of Interventions2019
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controlsWorld Psychiatry, 2017
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysisWorld Psychiatry, 2015
- Comorbidities and Mortality in Bipolar DisorderJAMA Psychiatry, 2013
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002